EVMN

Evommune Inc

59 hedge funds and large institutions have $466M invested in Evommune Inc in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$92.6M
2 +$65M
3 +$36.2M
4
NFGH
Nan Fung Group Holdings
Hong Kong
+$27.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$24.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EFM
1
EQT Fund Management
Luxembourg
$84.4M
RCM
2
RA Capital Management
Massachusetts
$59.2M
PBPIA
3
Pivotal bioVenture Partners Investment Advisor
California
$33M
AP
4
Andera Partners
$32.5M
NFGH
5
Nan Fung Group Holdings
Hong Kong
$24.7M
JP Morgan Chase
6
JP Morgan Chase
New York
$22.4M
RI
7
RTW Investments
New York
$22M
SCP
8
SymBiosis Capital Partners
Arkansas
$21.9M
Marshall Wace
9
Marshall Wace
United Kingdom
$16.9M
EAM
10
Eventide Asset Management
Massachusetts
$16.5M
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$13.4M
SAM
12
Sectoral Asset Management
Quebec, Canada
$10.1M
Verition Fund Management
13
Verition Fund Management
Connecticut
$9.68M
Aberdeen Group
14
Aberdeen Group
United Kingdom
$8.99M
VCIM
15
Velan Capital Investment Management
Georgia
$8.68M
Vanguard Group
16
Vanguard Group
Pennsylvania
$8.6M
OCA
17
Octagon Capital Advisors
New York
$8.56M
American Century Companies
18
American Century Companies
Missouri
$7.15M
Federated Hermes
19
Federated Hermes
Pennsylvania
$5.56M
GPP
20
Great Point Partners
Connecticut
$5.56M
NCM
21
NEXTBio Capital Management
California
$3.91M
DCM
22
Defilade Capital Management
California
$3.69M
KCM
23
Kynam Capital Management
New Jersey
$3.18M
ACM
24
ADAR1 Capital Management
Texas
$3.15M
MIM
25
Monashee Investment Management
Massachusetts
$3.14M